Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

A retrospective observational study of rapid titration of venetoclax (VEN) in patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL).

View Full Paper
Ask AI
Bookmark
Share

Authors

TBTijesuni BabalolaEAEmily C. AyersMDMichael G. Douvas

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Babalola et al. (2024) studied this question.

synapsesocial.com/papers/68e66db4b6db6435875f86bfhttps://doi.org/10.1200/jco.2024.42.16_suppl.e19018
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL2026
  2. 2Real-world outcome of low-frequency outpatient monitoring for venetoclax initiation in CLL: Single-center experience.2026
  3. 3Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience2025
  4. 4Phase 1 study of venetoclax combined with a 10-day regimen of decitabine in subjects with high-risk acute myeloid leukemia.2026
  5. 5Predicting the toxicity-efficacy ratio of venetoclax in real-world patients2025